Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZOSTAVAX in HIV-1-infected adults
NCT00851786Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2009
- Primary completion
- Sep 2011
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of zoster vaccine, live in herpes zoster (HZ), sponsored by National Institute of Allergy and Infectious Diseases. Started Apr 2009; status: completed.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT00851786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00851786.